2 research outputs found
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia
Resistance to L-asparaginase in leukemic cells may be caused by an
elevated cellular expression of asparagine synthetase (AS). Previously, we
reported that high AS expression did not correlate to L-asparaginase
resistance in TEL-AML1-positive B-lineage acute lymphoblastic leukemia
(ALL). In the present study we confirmed this finding in TEL-AML1-positive
patients (n = 28) using microarrays. In contrast, 35
L-asparaginase-resistant TEL-AML1-negative B-lineage ALL patients had a
significant 3.5-fold higher AS expression than 43 sensitive patients (P <
.001). Using real-time quantitative polymerase chain reaction (RTQ-PCR),
this finding was confirmed in an independent group of 39 TEL-AML1-negative
B-lineage ALL patients (P = .03). High expression of AS was associated
with poor prognosis (4-year probability of disease-free survival [pDFS]
58% +/- 11%) compared with low expression (4-year pDFS 83% +/- 7%; P =
.009). We conclude that resistance to l-asparaginase and relapse risk are
associated with high expression of AS in TEL-AML1-negative but not
TEL-AML1-positive B-lineage ALL
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL
The (12;21) translocation resulting in TEL/AML1 gene fusion is present in
about 25% of childhood precursor B-lineage acute lymphoblastic leukemia
(ALL) and is associated with a good prognosis and a high cellular
sensitivity to L-asparaginase (L-Asp). ALL cells are thought to be
sensitive to L-Asp due to lower asparagine synthetase (AS) levels.
Resistance to L-Asp may be caused by an elevated cellular level of AS or
by the ability of resistant cells to rapidly induce the expression of the
AS gene on L-Asp exposure. AS may be a target regulated by t(12;21). We
studied the relationship between t(12;21) and the mRNA level of AS to
investigate a possible mechanism underlying L-Asp sensitivity. Real-time
quantitative reverse transcription-polymerase chain reaction (RT-PCR)
analysis surprisingly revealed that 30 patients positive for t(12;21)
expressed 5-fold more AS mRNA compared with 17 patients negative for
t(12;21) (P =.008) and 11 samples from healthy controls (P =.016). The
mRNA levels of AS between t(12;21)(-) ALL and healthy controls did not
differ. No difference was found between ALL patients positive or negative
for t(12;21) in the capacity to up-regulate AS after in vitro L-Asp
exposure, excluding a defective capacity for t(12;21) cells in
up-regulating AS on L-Asp exposure. Moreover, no correlation was observed
between AS mRNA expression and sensitivity to L-Asp. We conclude that the
sensitivity of t(12;21)(+) childhood ALL to L-Asp is not associated with
the expression level of the AS gene. Furthermore, we contradict the
general thought that leukemic cells specifically lack AS compared with
normal bone marrow and blood cells